Search research articles
Contact Us
Filters
Showing results (31-40 of 59) with videos related to
Page
of 6
Sort By:
Vaccines
|
September 23, 2018
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
Ki-Hye Kim, Young-Man Kwon, Young-Tae Lee, et al.
Journal for Immunotherapy of Cancer
|
March 21, 2025
Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment
Jayalakshmi Thiruppathi, Veena Vijayan, Hye Suk Hwang, et al.
Journal of Virology
|
September 11, 2015
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells
Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, et al.
Vaccine
|
June 22, 2014
AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection
Yu-Na Lee, Min-Chul Kim, Young-Tae Lee, et al.
Virology
|
September 11, 2018
Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine
Ki-Hye Kim, Young-Man Kwon, Young-Tae Lee, et al.
Virology
|
January 2, 2015
Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease
Yu-Na Lee, Hye Suk Hwang, Min-Chul Kim, et al.
Antiviral Research
|
June 1, 2019
The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants
Youri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Expert Review of Vaccines
|
August 4, 2022
Vaccines against SARS-CoV-2 variants and future pandemics
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Plos One
|
October 16, 2015
Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, et al.
Journal of Virology
|
March 27, 2026
Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity
Ki-Hye Kim, Hye Suk Hwang, Surya Sekhar Pal, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 59) with videos related to
Sort By:
Page
of 6
Vaccines
|
September 23, 2018
Virus-Like Particles Are a Superior Platform for Presenting M2e Epitopes to Prime Humoral and Cellular Immunity against Influenza Virus
Ki-Hye Kim, Young-Man Kwon, Young-Tae Lee, et al.
Journal for Immunotherapy of Cancer
|
March 21, 2025
Thermoresistant flagellin-adjuvanted cancer vaccine combined with photothermal therapy synergizes with anti-PD-1 treatment
Jayalakshmi Thiruppathi, Veena Vijayan, Hye Suk Hwang, et al.
Journal of Virology
|
September 11, 2015
Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells
Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, et al.
Vaccine
|
June 22, 2014
AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection
Yu-Na Lee, Min-Chul Kim, Young-Tae Lee, et al.
Virology
|
September 11, 2018
Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine
Ki-Hye Kim, Young-Man Kwon, Young-Tae Lee, et al.
Virology
|
January 2, 2015
Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease
Yu-Na Lee, Hye Suk Hwang, Min-Chul Kim, et al.
Antiviral Research
|
June 1, 2019
The efficacy of inactivated split respiratory syncytial virus as a vaccine candidate and the effects of novel combination adjuvants
Youri Lee, Eun-Ju Ko, Ki-Hye Kim, et al.
Expert Review of Vaccines
|
August 4, 2022
Vaccines against SARS-CoV-2 variants and future pandemics
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Plos One
|
October 16, 2015
Alum Adjuvant Enhances Protection against Respiratory Syncytial Virus but Exacerbates Pulmonary Inflammation by Modulating Multiple Innate and Adaptive Immune Cells
Ki-Hye Kim, Young-Tae Lee, Hye Suk Hwang, et al.
Journal of Virology
|
March 27, 2026
Type I interferon signaling is required for resistance to primary influenza virus infection and vaccine-induced long-term immunity
Ki-Hye Kim, Hye Suk Hwang, Surya Sekhar Pal, et al.
Page
of 6